| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101423497A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 05/06/2009 | CN101423491A Acenaphtho-heterocycles compounds and application thereof in preparation of BH3 analogue Bcl-2 family protein inhibitor |
| 05/06/2009 | CN101423489A Indoline-2-one derivates and uses thereof |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/05/2009 | US7528258 Trityl olmesartan medoxomil is reacted with an acid in a water miscible organic solvent, separating the precipitate of triphenyl carbinol from the solution of olmesartan medoxomil; solution of olmesartan medoxomil is treated with a base to obtain a precipitate of olmesartan medoxomil |
| 05/05/2009 | US7528167 Inhibitors of papilloma virus |
| 05/05/2009 | US7528165 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure |
| 05/05/2009 | US7528157 EP4 receptor antagonists |
| 05/05/2009 | US7528137 Compounds, compositions, and methods |
| 05/05/2009 | US7528134 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 05/05/2009 | CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 05/05/2009 | CA2322953C Pyridine derivative and pharmaceutical containing the same |
| 04/30/2009 | WO2009055519A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | WO2009055516A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | WO2009054984A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | WO2009025839A3 Phosphodiesterase 10 inhibitors |
| 04/30/2009 | WO2009015037A3 5-pyridinone substituted indazoles |
| 04/30/2009 | WO2009012482A3 5-membered heterocyclic amides and related compounds |
| 04/30/2009 | WO2008141119A3 Modulators of cftr |
| 04/30/2009 | WO2008140553A4 Mapk/erk kinase inhibitors |
| 04/30/2009 | WO2008126106A8 Novel and improved processes for the preparation of intermediates of darifenacin, darifenacin and its pharmaceutically acceptable salts |
| 04/30/2009 | US20090111992 Alkyl ether derivatives or salts thereof |
| 04/30/2009 | US20090111986 Novel crystals of pyrimidine compound and process for producing the same |
| 04/30/2009 | US20090111809 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/30/2009 | US20090111151 Production of Polyketides |
| 04/30/2009 | US20090110662 Modification of biological targeting groups for the treatment of cancer |
| 04/30/2009 | CA2704040A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | CA2703717A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | CA2702126A1 Heterocycle amide t-type calcium channel antagonists |
| 04/30/2009 | CA2701594A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | CA2701292A1 Process for making thienopyrimidine compounds |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP1828127A4 INSECTICIDAL BIS(SUBSTITUTED PHENYL)-1-äÝ4-(SATURATED HETEROCYCLYL-SUBSTITUTED)PHENYLMETHYL¨-(4-PIPERIDYL)üMETHANE DERIVATIVES |
| 04/29/2009 | EP1786475B1 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 04/29/2009 | EP1765812B1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 04/29/2009 | EP1670769B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/29/2009 | EP1651592B1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1345910B1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof |
| 04/29/2009 | CN101421624A Methods for detecting substances which bind to the amyloid precursor protein or beta amyloid fragments, and binding compounds |
| 04/29/2009 | CN101421258A Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 04/29/2009 | CN101421250A 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 04/29/2009 | CN101421240A Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof |
| 04/29/2009 | CN100482659C Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
| 04/29/2009 | CN100482229C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524959 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524869 Taxanes having a C10 ester substituent |
| 04/28/2009 | US7524864 Methods of treating sleep disorders |
| 04/28/2009 | US7524862 Melanin-concentrating hormone (MCH); for the treatment of metabolic disorders and/or eating disorders, such as obesity and diabetes, also drug dependencies, and urinary incontinence |
| 04/28/2009 | US7524861 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 04/28/2009 | US7524855 (4-Chloro-2-{[4-(2,4-diamino-pyrimidin-5-ylmethyl)-6,7-dimethoxy-benzofuran-2-ylmethyl]-amino}-phenyl)-pyrrolidin-1-yl-methanone; dihydrofolate reductase; bactericide; grampositive (Staphylococcus aureusand, Enterococcus faecalis) and and gramnegative pathogens (Escherichia coli, Haemophilus influenzae) |
| 04/28/2009 | US7524854 Trimethoprim derivative; 5-[6,7-Dimethoxy-2-(7-methoxy-1H-indol-3-ylmethyl)-benzofuran-4-ylmethyl]-pyrimidine-2,4-diamine; potent activity against dihydrofolate reductase, mutated enzyme; superior bioavailability, antibacterial activity; gram positive and negative pathogens |
| 04/28/2009 | US7524849 5-arylpyrimidines as anticancer agents |
| 04/28/2009 | US7524848 Diaza heterocyclic amide compounds and their uses |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 04/28/2009 | US7524837 Benzotriazapinone salts and methods for using same |
| 04/28/2009 | CA2555258C 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-ht4 receptor agonistic activity |
| 04/28/2009 | CA2525437C Benzamide inhibitors of the p2x7 receptor |
| 04/28/2009 | CA2507465C Phenyl substituted piperidine compounds for use as ppar activators |
| 04/28/2009 | CA2425704C Tissue-specific exogenous optical agents |
| 04/28/2009 | CA2375259C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/28/2009 | CA2273328C 5-cyclo indole compounds as 5-ht1d receptor ligands |
| 04/28/2009 | CA2227762C Substituted aminouracils |
| 04/23/2009 | WO2009052237A1 Inhibitors of c-fms kinase |
| 04/23/2009 | WO2009052065A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009052063A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
| 04/23/2009 | WO2009052062A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009051660A2 Compounds for activating tgf-beta signaling |
| 04/23/2009 | WO2009051112A1 Amide compounds and use of the same |
| 04/23/2009 | WO2009050999A1 Indolium compound and optical recording material using the compound |
| 04/23/2009 | WO2009050352A2 Imidazolone derivatives, preparation method thereof and biological use of same |
| 04/23/2009 | WO2009050232A1 Cgrp antagonists |
| 04/23/2009 | WO2009050220A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050201A2 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 04/23/2009 | WO2009050200A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
| 04/23/2009 | WO2009050197A2 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 04/23/2009 | WO2009050185A1 1,3,5-trisubstituted triazole derivative |
| 04/23/2009 | WO2009049837A1 Process for preparing 8-hydrazino-8-aryloctanoyl derivatives and their use |
| 04/23/2009 | WO2009024342A3 Novel microbiocides |
| 04/23/2009 | WO2009015164A3 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/23/2009 | WO2009010230A3 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast |
| 04/23/2009 | WO2009004383A3 Aza-bicyclohexane compounds useful as anticoagulants |
| 04/23/2009 | WO2009004171A3 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 04/23/2009 | WO2009001060A3 Use of compounds for preparing anti-tuberculosis agents |
| 04/23/2009 | WO2008152094A3 Substituted acetamides as modulators of the ep2 receptor |
| 04/23/2009 | WO2008152014A3 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases |
| 04/23/2009 | WO2008131501A3 New anti-viral nucleoside analogs |
| 04/23/2009 | US20090105306 Novel compounds as cannabinoid receptor ligands |
| 04/23/2009 | US20090105296 Inhibitors of c-fms kinase |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105286 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors |
| 04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |